Literature DB >> 9761975

The use of mycophenolate mofetil (Cellcept) in renal transplantation.

Y Vanrenterghem1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9761975     DOI： 10.1159/000059931

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN： 0302-5144            Impact factor:   1.580


× No keyword cloud information.
  2 in total

1.  Mycophenolate Mofetil after Rituximab for Childhood-Onset Complicated Frequently-Relapsing or Steroid-Dependent Nephrotic Syndrome.

Authors:  Kazumoto Iijima; Mayumi Sako; Mari Oba; Seiji Tanaka; Riku Hamada; Tomoyuki Sakai; Yoko Ohwada; Takeshi Ninchoji; Tomohiko Yamamura; Hiroyuki Machida; Yuko Shima; Ryojiro Tanaka; Hiroshi Kaito; Yoshinori Araki; Tamaki Morohashi; Naonori Kumagai; Yoshimitsu Gotoh; Yohei Ikezumi; Takuo Kubota; Koichi Kamei; Naoya Fujita; Yasufumi Ohtsuka; Takayuki Okamoto; Takeshi Yamada; Eriko Tanaka; Masaki Shimizu; Tomoko Horinouchi; Akihide Konishi; Takashi Omori; Koichi Nakanishi; Kenji Ishikura; Shuichi Ito; Hidefumi Nakamura; Kandai Nozu
Journal:  J Am Soc Nephrol       Date:  2021-12-08       Impact factor: 10.121

2.  Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07).

Authors:  Tomoko Horinouchi; Mayumi Sako; Koichi Nakanishi; Kenji Ishikura; Shuichi Ito; Hidefumi Nakamura; Mari Saito Oba; Kandai Nozu; Kazumoto Iijima
Journal:  BMC Nephrol       Date:  2018-11-01       Impact factor: 2.388
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.